These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27793210)

  • 1. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer.
    Idris S; Lindsay C; Kostiuk M; Andrews C; Côté DW; O'Connell DA; Harris J; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):54. PubMed ID: 27793210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
    Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
    Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
    Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
    Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs.
    Isaac A; Kostiuk M; Zhang H; Lindsay C; Makki F; O'Connell DA; Harris JR; Cote DW; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):5. PubMed ID: 28088212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
    Boscolo-Rizzo P; Pawlita M; Holzinger D
    Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
    Anayannis NV; Schlecht NF; Belbin TJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
    Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
    Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.
    Dogan S; Xu B; Middha S; Vanderbilt CM; Bowman AS; Migliacci J; Morris LGT; Seshan VE; Ganly I
    Int J Cancer; 2019 Dec; 145(11):3152-3162. PubMed ID: 31093971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Functional Splice Variant of
    Guo T; Sakai A; Afsari B; Considine M; Danilova L; Favorov AV; Yegnasubramanian S; Kelley DZ; Flam E; Ha PK; Khan Z; Wheelan SJ; Gutkind JS; Fertig EJ; Gaykalova DA; Califano J
    Cancer Res; 2017 Oct; 77(19):5248-5258. PubMed ID: 28733453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
    Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
    Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence Changes of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma and Effects on Survival in the Netherlands Cancer Institute, 1980-2009.
    Henneman R; Van Monsjou HS; Verhagen CV; Van Velthuysen ML; Ter Haar NT; Osse EM; Lopez-Yurda MI; Balm AJ; Van Den Brekel MW
    Anticancer Res; 2015 Jul; 35(7):4015-22. PubMed ID: 26124350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV in oropharyngeal cancer: the basics to know in clinical practice.
    Elrefaey S; Massaro MA; Chiocca S; Chiesa F; Ansarin M
    Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):299-309. PubMed ID: 25709145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
    Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
    Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
    Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS
    Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications.
    Allen CT; Lewis JS; El-Mofty SK; Haughey BH; Nussenbaum B
    Laryngoscope; 2010 Sep; 120(9):1756-72. PubMed ID: 20669304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.